Ahmed Kotb/X
Jul 26, 2026, 13:32
Ahmed Kotb: A Practical Guide to Von Willebrand Disease
Ahmed Kotb, Ahmed Kotb, Hematologist and Bone Marrow Transplant Physician at King Faisal Specialist Hospital International Holding Company (KFSHI), shared a post on X:
”Von Willebrand Disease (VWD)
Type 1: Partial decrease in von Willebrand factor (VWF) – usually responds to desmopressin (DDAVP).
Type 2: Qualitative defect in VWF.
- Type 2A: Decreased high-molecular-weight (HMW) multimers.
- Type 2B: Increased binding to platelet glycoprotein Ib (GPIb), resulting in thrombocytopenia; avoid DDAVP.
- Type 2M: Decreased platelet adhesion.
- Type 2N: Decreased binding to factor VIII (FVIII).
Type 3: Complete absence of VWF, causing severe disease; treat with VWF/FVIII concentrate.
Laboratory findings: Decreased VWF antigen, decreased VWF activity, and factor VIII may be decreased.”
Stay updated with Hemostasis Today.
-
Jul 26, 2026, 14:45Sarah Giorgia Grazia Giannone: An Exciting Chapter in Gene Therapy Research
-
Jul 26, 2026, 14:21Javed Anees: Cerebral Collateral Circulation in Acute Ischemic Stroke
-
Jul 26, 2026, 14:11André Picard։ Canadian Blood Supplies Drop Sharply, Urgent Donor Appeal Issued
-
Jul 26, 2026, 13:54Lorenzo Scalia: New Review Highlights Anticoagulant Strategies for Elderly Patients With Atrial Fibrillation
-
Jul 26, 2026, 12:42Emmanuel J Favaloro: Celebrating Excellence in Scientific Peer Review
-
Jul 26, 2026, 12:20Advancing Sickle Cell Care Through Advocacy – American Society of Hematology
-
Jul 26, 2026, 12:04Paolo Zamboni: Marking 50 Years in Medicine
-
Jul 26, 2026, 11:55William Wallace: Muscle Aging Emerges as the Strongest Mortality Predictor
-
Jul 26, 2026, 08:51Dayita Banerjee: Presenting New Insights in Fibrinolysis Research at ISTH 2026